## **Core Concept**
Non-depolarizing neuromuscular blockers (NDNMBs) primarily act by competitively inhibiting the **nicotinic acetylcholine receptors** at the neuromuscular junction. However, some NDNMBs can also exhibit cardiovascular effects due to their interaction with various receptors and ion channels in the cardiovascular system.

## **Why the Correct Answer is Right**
The correct answer involves understanding the mechanisms through which NDNMBs can exert cardiovascular effects. Some NDNMBs can cause **histamine release**, leading to vasodilation and increased vascular permeability. Others may have a direct effect on the heart or vasculature by blocking **muscarinic receptors** or affecting **sympathetic nervous system** activity. Additionally, certain NDNMBs can interact with **calcium channels** or have a direct **vasodilatory effect**. The cardiovascular effects can vary significantly between different NDNMBs.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately represent the primary factors responsible for the cardiovascular effects of NDNMBs.
- **Option B:** This option is incorrect as it also fails to accurately describe the main factors responsible for the cardiovascular effects of NDNMBs.
- **Option D:** This option is incorrect because it likely includes factors not primarily associated with the cardiovascular effects of NDNMBs.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that **atracurium** and **mivacurium** are NDNMBs known to cause significant **histamine release**, leading to notable cardiovascular effects such as hypotension and tachycardia. Recognizing these agents and their side effects is crucial for managing patients undergoing surgery.

## **Correct Answer:** .